These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 1362540)
1. Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis. Rastogi N; Ross BC; Dwyer B; Goh KS; Clavel-Sérès S; Jeantils V; Cruaud P Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):901-7. PubMed ID: 1362540 [TBL] [Abstract][Full Text] [Related]
2. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Rastogi N; Labrousse V; Goh KS Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093 [TBL] [Abstract][Full Text] [Related]
4. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis. Krüüner A; Pehme L; Ghebremichael S; Koivula T; Hoffner SE; Mikelsaar M Clin Infect Dis; 2002 Jul; 35(2):146-55. PubMed ID: 12087520 [TBL] [Abstract][Full Text] [Related]
5. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics. Wilkinson D; Pillay M; Davies GR; Sturm AW Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521 [TBL] [Abstract][Full Text] [Related]
6. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays]. Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinical Trials Group 222 Protocol Team. Perlman DC; El Sadr WM; Heifets LB; Nelson ET; Matts JP; Chirgwin K; Salomon N; Telzak EE; Klein O; Kreiswirth BN; Musser JM; Hafner R AIDS; 1997 Oct; 11(12):1473-8. PubMed ID: 9342069 [TBL] [Abstract][Full Text] [Related]
8. Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi. Ndung'u PW; Kariuki S; Ng'ang'a Z; Revathi G J Infect Dev Ctries; 2012 Jan; 6(1):33-9. PubMed ID: 22240426 [TBL] [Abstract][Full Text] [Related]
9. Strain differentiation of Mycobacterium tuberculosis complex isolated from sputum of pulmonary tuberculosis patients. Abbadi S; El Hadidy G; Gomaa N; Cooksey R Int J Infect Dis; 2009 Mar; 13(2):236-42. PubMed ID: 18838283 [TBL] [Abstract][Full Text] [Related]
10. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis. Fattorini L; Iona E; Ricci ML; Thoresen OF; Orrù G; Oggioni MR; Tortoli E; Piersimoni C; Chiaradonna P; Tronci M; Pozzi G; Orefici G Microb Drug Resist; 1999; 5(4):265-70. PubMed ID: 10647084 [TBL] [Abstract][Full Text] [Related]
11. Genetic diversity and evidence for acquired antimicrobial resistance in Mycobacterium tuberculosis at a large hospital in South India. Harris KA; Mukundan U; Musser JM; Kreiswirth BN; Lalitha MK Int J Infect Dis; 2000; 4(3):140-7. PubMed ID: 11179917 [TBL] [Abstract][Full Text] [Related]
12. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. Bhusal Y; Shiohira CM; Yamane N Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578 [TBL] [Abstract][Full Text] [Related]
13. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia. Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231 [TBL] [Abstract][Full Text] [Related]
14. [Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results]. Belianin II; Shmelev EI Probl Tuberk Bolezn Legk; 2007; (2):31-8. PubMed ID: 17419333 [TBL] [Abstract][Full Text] [Related]
15. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. Small PM; Shafer RW; Hopewell PC; Singh SP; Murphy MJ; Desmond E; Sierra MF; Schoolnik GK N Engl J Med; 1993 Apr; 328(16):1137-44. PubMed ID: 8096066 [TBL] [Abstract][Full Text] [Related]
16. Prospects for development of new antimycobacterial drugs. Tomioka H J Infect Chemother; 2000 Mar; 6(1):8-20. PubMed ID: 11810525 [TBL] [Abstract][Full Text] [Related]
17. [Lomefloxacin in complex treatment of acute progressive form of pulmonary tuberculosis]. Sokolova GB; Kunichan AD; Koriakin VA; Lazareva IaV Antibiot Khimioter; 1998; 43(10):10-2. PubMed ID: 9825102 [TBL] [Abstract][Full Text] [Related]
18. Association between Mycobacterium tuberculosis complex phylogenetic lineage and acquired drug resistance. Yuen CM; Kurbatova EV; Click ES; Cavanaugh JS; Cegielski JP PLoS One; 2013; 8(12):e83006. PubMed ID: 24376623 [TBL] [Abstract][Full Text] [Related]
19. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Somoskovi A; Parsons LM; Salfinger M Respir Res; 2001; 2(3):164-8. PubMed ID: 11686881 [TBL] [Abstract][Full Text] [Related]
20. Drug resistance and IS6110-RFLP patterns of Mycobacterium tuberculosis in patients with recurrent tuberculosis in northern Thailand. Sukkasem S; Yanai H; Mahasirimongkol S; Yamada N; Rienthong D; Palittapongarnpim P; Khusmith S Microbiol Immunol; 2013 Jan; 57(1):21-9. PubMed ID: 23106595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]